Genetic and Protein Markers Related to in situ Growth and Multiplicity in Small Sporadic Colorectal Adenomas

References

• Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525–32.
   PubMed Web of Science ®Google Scholar
• Kinzler KW, Vogelstein B. Lessons from Hereditary Colorectal Cancer. Cell 1996; 87: 159–70.
   PubMed Web of Science ®Google Scholar
• Jen J, Powell SM, Papadopoulos N, Smith KJ, Hamolton SR, Vogelstein B, et al. Molecular determinants of dysplasia in colorectal lesions. Cancer Res 1994; 54: 5523–6.
   PubMed Web of Science ®Google Scholar
• Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC (see comments). Science 1997; 275: 1787–90.
   PubMed Web of Science ®Google Scholar
• Ilyas M, Tomlinson I, Rowan A, Pignatelli M, Bodmer W. B-catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci 1997; 94: 10330–4.
   PubMed Web of Science ®Google Scholar
• Hao XP, Frayling IM, Sgouros JG, Du MQ, Willcocks TC, Talbot IC, et al. The spectrum of p53 mutations in colorectal adenomas differs from that in colorectal carcinomas. Gut 2002; 50: 834–9.
   PubMed Web of Science ®Google Scholar
• Knoernchild H. Growth rate and malignant potential of colonic polyps: early results. Surg Forum 1963; 14: 137–8.
   PubMedGoogle Scholar
• Hoff G, Vatn M, Gjone E, Larsen S, Sauar J. Epidemiology of polyps in the rectum and sigmoid colon. Design of a population screening study. Scand J Gastroenterol 1985; 20: 351–5.
   PubMed Web of Science ®Google Scholar
• Hofstad B, Vatn MH, Andersen SN, Huitfeldt HS, Rognum T, Larsen S, et al. Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of three years (see comments). Gut 1996; 39: 449–56.
   PubMed Web of Science ®Google Scholar
• Villavicencio RT, Rex DK. Colonic adenomas: prevalence and incidence rates, growth rates, and miss rates at colonoscopy. Semin Gastrointest Dis 2000; 11: 185–93.
   PubMedGoogle Scholar
• Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991; 138: 867–73.
   PubMed Web of Science ®Google Scholar
• Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124: 1–6.
   PubMed Web of Science ®Google Scholar
• Craig RW. The bcl-2 gene family. Semin Cancer Biol 1995;6: 35–13.
   PubMed Web of Science ®Google Scholar
• Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. (Erratum appears in Nat Med 1997 Aug;3(8):934.). Nat Med 1997; 3: 614–20.
   Web of Science ®Google Scholar
• Hofstad B, Vatn M, Hoff G, Larsen S, Osnes M. Growth of colorectal polyps: design of a prospective, randomized, placebo-controlled intervention study in patients with colorectal polyps. (Published erratum appears in Eur J Cancer Prev 1993 Mar; 2(2): 189). Eur J Cancer Prevention 1992; 1: 415–22.
   Google Scholar
• Hofstad B, Vatn M, Larsen S, Osnes M. Reliability of in situ measurements of colorectal polyps. Scand J Gastroenterol 1992; 27: 59–64.
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P. Mucosal and glandular distribution of immunoglobulin components. Immunohistochemistry with a cold ethanol-fixation technique. Immunology 1974; 26: 1101–14.
   PubMed Web of Science ®Google Scholar
• Norheim Andersen S, Lovig T, Fausa O, Rognum TO. Germline and somatic mutations in exon 15 of the APC gene and K-ras mutations in duodenal adenomas in patients with familial adenomatous polyposis (see comments). Scand J Gastroenterol 1999; 34: 611–7.
   PubMed Web of Science ®Google Scholar
• Lamlum H, Papadopoulou A, Ilyas M, Rowan A, Gillet C, Hanby A, et al. APC mutations are sufficient for the growth of early colorectal adenomas. Proc Natl Acad Sci USA 2000; 97: 2225–8.
   PubMed Web of Science ®Google Scholar
• Norheim Andersen S, Breivik J, Løvig T, Meling GI, Gaudernack G, Clausen OPF, et al. K-ras mutations and HLA- DR expression in large bowel adenomas. Br J Cancer 1996; 74: 99–108.
   PubMed Web of Science ®Google Scholar
• Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248–57.
   PubMed Web of Science ®Google Scholar
• Dimo-Simonin N., Brandt-Cassadevall, Gujer H-R. Chemilumi-nescent DNA probes: evaluation and usefulness in forensic cases. Forensic Sei Int 1992; 57: 119–27.
   PubMed Web of Science ®Google Scholar
• Lothe RA, Andersen SN, Hofstad B, Meling GI, Peltomäki P, Heim S, et al. Deletion of 1p loci and microsatellite instability in colorectal polyps. Genes Chromosomes Cancer 1995; 14: 182–8.
   PubMed Web of Science ®Google Scholar
• Norheim Andersen S, Rognum TO, Lund E., Meling GI, Hauge S. Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis. Br J Cancer 1993; 68: 80–5.
   PubMed Web of Science ®Google Scholar
• Breivik J, Meling GI, Spurkland A, Rognum TO, Gaudernack G. K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location. Br J Cancer 1994; 69: 367–71.
   PubMed Web of Science ®Google Scholar
• McLellan EA, Owen RA, Stepniewska KA, Sheffield JP, Lemoine NR. High frequency of K-ras mutations in sporadic colorectal adenomas. Gut 1993; 34: 392–6.
   PubMed Web of Science ®Google Scholar
• Rashid A, Zahurak M, Goodman SN, Hamilton SR. Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas. Gut 1999; 44: 826–33.
   PubMed Web of Science ®Google Scholar
• Maltzman T, Knoll K, Martinez ME, Byers T, Stevens BR, Marshall JR, et al. Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: relationship to histologic and clinical characteristics. Gastroenterology 2001;121:302–9.
   PubMed Web of Science ®Google Scholar
• Takayama T, Katsuki S, Takahashi Y, Ohi M, Nojiri S, Sakamaki S, et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 1998; 339: 1277–84.
   PubMed Web of Science ®Google Scholar
• Takayama T, Ohi M, Hayashi T, Miyanishi K, Nobuoka A, Nakajima T, et al. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology 2001; 121: 599–611.
   PubMed Web of Science ®Google Scholar
• Otori K, Oda Y, Sugiyama K, Hasebe T, Mukai K, Fujii T, et al. High frequency of K-ras mutations in human colorectal hyperplastic polyps (see comments). Gut 1997; 40: 660–3.
   PubMed Web of Science ®Google Scholar
• Rashid A, Houlihan PS, Booker S, Petersen GM, Giardiello FM, Hamilton SR. Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 2000; 119: 323–32.
   PubMed Web of Science ®Google Scholar
• Arends JW. Molecular interactions in the Vogelstein model of colorectal carcinoma. J Pathol 2000; 190: 412–6.
   PubMed Web of Science ®Google Scholar
• Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992; 359: 235–7.
   PubMed Web of Science ®Google Scholar
• Benedetti LD, Sciallero S, Gismondi V, James R, Bafico A, Biticchi R, et al. Association of APC gene mutations and histological characteristics of colorectal adenomas. Cancer Res 1994; 54: 3553–6.
   PubMed Web of Science ®Google Scholar
• Miyoshi Y, Nagase H, Ando H, Hon A, Ichii S, Nakatsuru S, et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1992; 1: 229–33.
   PubMedGoogle Scholar
• Mulkens J, Ponein J, Arends JW, De Goeij AF. APC mutations in human colorectal adenomas: analysis of the mutation cluster region with temperature gradient gel electrophoresis and clinicopathological features. J Pathol 1998;185:360–5.
   PubMed Web of Science ®Google Scholar
• Iwao K, Nakamori S, Kameyama M, Imaoka S, Kinoshita M, Fukui T, et al. Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res 1998;58: 1021–6.
   PubMed Web of Science ®Google Scholar
• Sparkes AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational analysis of the APC/b-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998;58: 1130–4.
   PubMed Web of Science ®Google Scholar
• Samowitz WS, Powers MD, Spirio LN, Nollet F, van Roy F, Slattery ML. b-Catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas. Cancer Res 1999; 59.
   Google Scholar
• Jen J, Kim H, Piantadosi S, Liu ZF, Levitt RC, Sistonen P, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994;331: 213–21.
   PubMed Web of Science ®Google Scholar
• Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990; 247: 49–56.
   PubMed Web of Science ®Google Scholar
• Young J, Leggett B, Gustafson C, Ward M, Searle J, Thomas L, et al. Genomic instability occurs in colorectal carcinomas but not in adenomas. Hum Mutat 1993; 2: 351–4.
   PubMed Web of Science ®Google Scholar
• Clarke A, Pudie C, Harrison D, Morris R, Bird C, Hooper M, et al. Tymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 362: 849–52.
   PubMed Web of Science ®Google Scholar
• Partik G, Kahl-Rainer P, Sedivy R, Ellinger A, Bursch W, Marian B. Apoptosis in human colorectal tumours: ultrastructure and quantitative studies on tissue localization and association with bak expression. Virchows Arch 1998; 432: 415–26.
   PubMed Web of Science ®Google Scholar
• Nomura M, Watari J, Yokota K, Saitoh Y, Obara T, Kohgo Y. Morphogenesis of nonpolypoid colorectal adenomas and early carcinomas assessed by cell proliferation and apoptosis. Virchows Arch 2000; 437: 17–24.
   PubMed Web of Science ®Google Scholar
• Bosari S, Moneghini L, Graziani D, Lee AK, Murray JJ, Coggi G, et al. bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas. Hum Pathol 1995; 26: 534–40.
   PubMed Web of Science ®Google Scholar
• Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995; 55: 237–41.
   PubMed Web of Science ®Google Scholar
• Kikuchi Y, Dinjens WN, Bosman FT. Proliferation and apoptosis in proliferative lesions of the colon and rectum. Virchows Arch 1997; 431: 111–7.
   PubMed Web of Science ®Google Scholar
• Kyzer S, Gordon PH. Determination of proliferative activity in colorectal carcinoma using monoclonal antibody K?67. Dis Colon Rectum 1997; 40: 322–5.
   PubMed Web of Science ®Google Scholar
• Jansson A, Sun X. Ki-67 expression in relation to clinicopatho- logical variables and prognosis in colorectal adenocarcinomas. APMIS 1997; 105: 730–4.
   PubMed Web of Science ®Google Scholar
• Bomme L, Heim S, Bardi G, Fenger C, Kronborg O, Brogger A, et al. Allelic imbalance and cytogenetic deletion of lp in colorectal adenomas: a target region identified between DIS 199 and DIS234. Genes Chromosomes Cancer 1998; 21: 185–94.
   PubMed Web of Science ®Google Scholar
• Dietrich W, Lander E, Smith J, Moser A, Gould K, Luongo C, et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 1993;75: 631–9.
   PubMed Web of Science ®Google Scholar
• MacPhee M, Chepenik KP, Liddell RA, Nelson KK, Siracusa LD, Buchberg AM. The secretory phospholipase A2 gene is a candidate for the Moml locus, a major modifier of ApcMin- induced intestinal neoplasia. Cell 1995; 81: 957–66.
   PubMed Web of Science ®Google Scholar
• Riggins GJ, Markowitz S, Wilson JK, Vogelstein B, Kinzler KW. Absence of secretory phospholipase A2 gene alterations in human colorectal cancer. Cancer Res 1995; 55: 5184–6.
   PubMed Web of Science ®Google Scholar
• Dobbie Z, Heinimann K, Bishop DT, Muller H, Scott RJ. Identification of a modifier gene locus on chromosome lp35-36 in familial adenomatous polyposis. Hum Genet 1997;99: 653–7.
   PubMed Web of Science ®Google Scholar
• Nimmrich I, Friedl W, Kruse R, Pietsch S, Hentsch S, Deuter R, et al. Loss of the PLA2G2A gene in a sporadic colorectal tumor of a patient with a PLA2G2A germline mutation and absence of PLA2G2A germline alterations in patients with FAP. Hum Genet 1997;100: 345–9.
   PubMed Web of Science ®Google Scholar
• Jost CA, Marin MC, Kaelin WG, Jr. p73 is a simian [correction of human] p53-related protein that can induce apoptosis (see comments). (Published erratum appears in Nature 1999 Jun 24;399(6738):817). Nature 1997;389: 191–4.
   PubMed Web of Science ®Google Scholar
• Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, et al. Monoallelically expressed gene related to p53 at Ip36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997; 90: 809–19.
   PubMed Web of Science ®Google Scholar
• Perri P, Praml C, Savelyeva L, Pillmann A, Schwab M. Fine mapping of distal lp loci reveals TP73 at D1S468. Cytogenet Cell Genet 1999; 84: 111–4.
   PubMedGoogle Scholar
• Praml C, Savelyeva L, Perri P, Schwab M. Cloning of the human aflatoxin Bl-aidehyde reductase gene at 1p35-1p36.1 in a region frequently altered in human tumor cells. Cancer Res 1998; 58: 5014–8.
   PubMed Web of Science ®Google Scholar